Tarsus Long Term Debt To Capitalization from 2010 to 2025

TARS Stock  USD 43.91  1.35  3.17%   
Tarsus Pharmaceuticals Long Term Debt To Capitalization yearly trend continues to be comparatively stable with very little volatility. Long Term Debt To Capitalization will likely drop to 0.09 in 2025. From the period from 2010 to 2025, Tarsus Pharmaceuticals Long Term Debt To Capitalization quarterly data regression had r-value of  0.44 and coefficient of variation of  12.54. View All Fundamentals
 
Long Term Debt To Capitalization  
First Reported
2010-12-31
Previous Quarter
0.12
Current Value
0.088
Quarterly Volatility
0.01198832
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tarsus Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tarsus Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 7.5 M or Depreciation And Amortization of 529.3 K, as well as many indicators such as Price To Sales Ratio of 13.51, Dividend Yield of 0.0 or PTB Ratio of 9.74. Tarsus financial statements analysis is a perfect complement when working with Tarsus Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Tarsus Pharmaceuticals Correlation against competitors.
For more information on how to buy Tarsus Stock please use our How to Invest in Tarsus Pharmaceuticals guide.

Latest Tarsus Pharmaceuticals' Long Term Debt To Capitalization Growth Pattern

Below is the plot of the Long Term Debt To Capitalization of Tarsus Pharmaceuticals over the last few years. It is Tarsus Pharmaceuticals' Long Term Debt To Capitalization historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tarsus Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Long Term Debt To Capitalization10 Years Trend
Slightly volatile
   Long Term Debt To Capitalization   
0.130.120.088100%
       Timeline  

Tarsus Long Term Debt To Capitalization Regression Statistics

Arithmetic Mean0.1
Geometric Mean0.09
Coefficient Of Variation12.54
Mean Deviation0.01
Median0.09
Standard Deviation0.01
Sample Variance0.0001
Range0.0435
R-Value0.44
Mean Square Error0.0001
R-Squared0.20
Significance0.09
Slope0
Total Sum of Squares0

Tarsus Long Term Debt To Capitalization History

2025 0.088
2024 0.12
2023 0.13

About Tarsus Pharmaceuticals Financial Statements

Tarsus Pharmaceuticals shareholders use historical fundamental indicators, such as Long Term Debt To Capitalization, to determine how well the company is positioned to perform in the future. Although Tarsus Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Tarsus Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Tarsus Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Long Term Debt To Capitalization 0.12  0.09 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Tarsus Stock Analysis

When running Tarsus Pharmaceuticals' price analysis, check to measure Tarsus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tarsus Pharmaceuticals is operating at the current time. Most of Tarsus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tarsus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tarsus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tarsus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Discover investing ideas

Utilize additional investing modules

News Freq…Investor S…